Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide

TERMINATED · PHASE3 · Rhabdomyosarcoma, Malignant Soft Tissue

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.